Coluracetam is a synthetic nootropic compound classified within the racetam family. Developed in Japan, it gained attention for its potential neurocognitive effects. Unlike some other racetams, Coluracetam's primary proposed mechanism of action is believed to involve a process called high-affinity choline uptake (HACU). This mechanism is distinct from the more common acetylcholine modulation seen with other nootropics. Research into Coluracetam's effects has primarily been conducted in animal models and, to a lesser extent, in human trials, exploring its potential applications in cognitive enhancement and conditions involving cognitive impairment. It is often discussed in the context of brain health and cognitive function, particularly concerning memory and learning processes. Coluracetam is not approved as a pharmaceutical drug in most countries and is typically available as a research chemical or dietary supplement.
Deep dive
Tap a section to expand.
Known interactions
Category rule: glp1 × supplement
Note
GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.
Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider.
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Frequently asked
Sources referenced
["PubChem (National Library of Medicine)", "DrugBank (University of Alberta)", "MedlinePlus (National Library of Medicine)"]
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the supplement category or studied for the same goals.
